Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells

54Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.

Abstract

Valency requirements for B cell activation upon antigen encounter are poorly understood. OB1 transnuclear B cells express an IgG1 B cell receptor (BCR) specific for ovalbumin (OVA), the epitope of which can be mimicked using short synthetic peptides to allow antigenspecific engagement of the BCR. By altering length and valency of epitope-bearing synthetic peptides, we examined the properties of ligands required for optimal OB1 B cell activation. Monovalent engagement of the BCR with an epitope-bearing 17-mer synthetic peptide readily activated OB1 B cells. Dimers of the minimal peptide epitope oriented in an N to N configuration were more stimulatory than their C to C counterparts. Although shorter length correlated with less activation, a monomeric 8-mer peptide epitope behaved as a weak agonist that blocked responses to cell-bound peptide antigen, a blockade which could not be reversed by CD40 ligation. The 8-mer not only delivered a suboptimal signal, which blocked subsequent responses to OVA, anti-IgG, and anti-kappa, but also competed for binding with OVA. Our results show that fine-tuning of BCR-ligand recognition can lead to B cell nonresponsiveness, activation, or inhibition. © 2014 Avalos et al.

Cite

CITATION STYLE

APA

Avalos, A. M., Bilate, A. M., Witte, M. D., Tai, A. K., He, J., Frushicheva, M. P., … Ploegh, H. L. (2014). Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells. Journal of Experimental Medicine, 211(2), 365–379. https://doi.org/10.1084/jem.20131603

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free